Diamyd Medical logo

Diamyd Medical

Developing precision medicine therapies for Type 1 Diabetes

45 employees · est. 1994 · Stockholm, Sweden

VS
Valeritas logo

Valeritas

Improving health and simplifying life for people with diabetes.

35 employees · est. 2006 · Bridgewater, United States

Diamyd Medical is the older company (1994 vs 2006).

Side-by-Side Comparison

Diamyd Medical Valeritas
Founded
1994 older 2006
Headquarters
Stockholm, Sweden Bridgewater, United States
Employees
45 35
Industry
Biotechnology Biotechnology, Health Care, Medical Devices
Funding Stage
Post Ipo Equity Series Unknown
Total Funding
Not tracked yet $355.00M
Funding Rounds
Not tracked yet 6
Services
Not tracked yet Not tracked yet
Target Customers
Not tracked yet Not tracked yet
Taxonomy
Not tracked yet Diabetes Management, Insulin Delivery, V-Go, H-Patch Technology, Innovative Drug Delivery, Patient Outcomes, Type 2 Diabetes, Continuous Glucose Monitoring, Health Technology, Clinical Outcomes, Discreet Insulin Delivery, Patient Convenience
Website
diamyd.com valeritas.com
Diamyd Medical logo

About Diamyd Medical

Diamyd Medical is a Swedish diabetes company developing precision medicine therapies for Type 1 Diabetes. The therapeutic diabetes vaccine Diamyd , an antigen-specific immunotherapy for the preservation of endogenous insulin production, is being evaluated in the ongoing Phase III trial DIAGNODE-3....

Valeritas logo

About Valeritas

Valeritas is a commercial-stage medical technology company focused on improving health and simplifying life for people with diabetes. Their flagship product, V-Go Wearable Insulin Delivery Device, is designed to help patients with Type 2 diabetes in managing their insulin levels. This small, discree...

We will tell you when either one moves

BounceWatch watches Diamyd Medical and Valeritas for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Diamyd Medical and Valeritas — by email.

Frequently Asked Questions

Diamyd Medical — Developing precision medicine therapies for Type 1 Diabetes. Valeritas — Improving health and simplifying life for people with diabetes.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Diamyd Medical has raised undisclosed funding while Valeritas has raised $355.00M.
Diamyd Medical and Valeritas operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Diamyd Medical with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Valeritas on 12 Sep 2024. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes